77 results
Page 3 of 4
8-K
EX-99.1
nwqi0hc8go8dppey
19 Jun 19
DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
4:05pm
8-K
EX-10.1
toz16fgdih3umkk1r0
4 Jun 19
Entry into a Material Definitive Agreement
7:30am
8-K
EX-3.2
ke9ga6k 6rqnqmis
4 Jun 19
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
324sfz4
23 May 19
Departure of Directors or Certain Officers
4:01pm
DEF 14A
i9brnifqqtje6x8hf
8 Apr 19
Definitive proxy
6:04am
PRE 14A
y7vkdz8s
20 Mar 19
Preliminary proxy
4:31pm
10-K
84oj7
19 Mar 19
Annual report
4:58pm
424B4
n5v3am sg74ifp7i
10 Dec 18
Prospectus supplement with pricing info
4:50pm
S-1/A
cr9 j6nfp
19 Nov 18
IPO registration (amended)
5:01pm
S-1
EX-4.2
58seqw6ykgq5 6cxj
9 Nov 18
IPO registration
4:21pm
S-1
EX-4.9
zadj560x27x1dff
9 Nov 18
IPO registration
4:21pm
S-1
3j23s2j yj
9 Nov 18
IPO registration
4:21pm
S-1
EX-4.1
w0qjgw
9 Nov 18
IPO registration
4:21pm
S-1
EX-10.1
8bzxu oz8zv9qpiukgj
9 Nov 18
IPO registration
4:21pm
S-1
EX-10.5
48hbd
9 Nov 18
IPO registration
4:21pm
S-1
EX-10.4
8muwd36zry5r8y ek
9 Nov 18
IPO registration
4:21pm
S-1
EX-3.5
wqe1zp rwg7sb6xm
9 Nov 18
IPO registration
4:21pm
S-1
EX-4.11
bt3g8ad
9 Nov 18
IPO registration
4:21pm